Accuracy of epidermal growth factor receptor mutation analysis on the basis of small biopsy specimens in patients with nonsmall cell lung cancer [3]

International Journal of Cancer

Volumn 119, Issue 7, 2006, Pages 1751-1752

  Fujita, Shiro ^a   Mio, Tadashi ^a   Sonobe, Makoto ^a   Kamiyama, Kiyofumi ^b   Masago, Katsuhiro ^a   Miyahara, Ryo ^a   Wada, Hiromi ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b SRL INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

BRONCHOSCOPY; CANCER CELL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DNA EXTRACTION; EXON; FEMALE; GENE MUTATION; HUMAN; JAPAN; LETTER; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR BIOPSY;

BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; MALE; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33747493409     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22012     Document Type: Letter

References (10)

1. Shin J-Y, Gow C-H, Yu C-J, Yang C-H, Chang Y-L, Tsai M-F, Hsu Y-C, Chen K-Y, Su W-P, Yang P-C. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer. Int J Cancer 2006;118:963-9.
2. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-1500.
3. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Branningan BA, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Chritiani DC, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
4. Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, Hatooka S, Shinoda M, Takahashi T, Yatabe Y. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol 2005;23:2513-20.
5. Takano T, Ohe Y, Sakamoto H, Tsuta K, Matsuno Y, Tateishi U, Yamamoto S, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Shibata T, et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 2005;23:6829-37.
6. Kim K-S, Jeong J-Y, Kim Y-C, Na K-J, Kim Y-H, Ahn S-J, Baek S-M, Park C-S, Park C-M, Kim Y-I, Lim S-C, Park K-O. Predictors of the response to gefitinib in refractory non-small cell lung cancer. Clin Cancer Res 2005;11:2244-51.
7. Rosell R, Ichinose Y, Taron M, Sarries C, Queralt C, Mendez P, Sanchez JM, Nishiyama K, Moran T, Cirauqui B, Mate JL, Besse B, et al. Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer. Lung Cancer 2005;50:25-33.
8. Cortes-Funes H, Gomez C, Rosell R, Valero P, Garcia-Giron C, Velasco A, Izquierdo A, Diz P, Camps C, Castellanos D, Alberola V, Cardenal F, et al. Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients. Ann Oncol 2005;16:1081-6.
9. Sonobe M, Manabe T, Wada H, Tanaka F. Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma. Br J Cancer 2005;93:355-63.
10. Cappuzzo F, Hirsh FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 2005;97:643-55.